Sinopharm Tech Holdings Limited (Stock Code: 8156) has scheduled a board meeting on 26 February 2026. The meeting is set to review and approve interim results for the six-month period ended 31 December 2025 and consider any potential dividend declaration.
The announcement, dated 11 February 2026, confirms that the board will discuss these key matters, and further details will be released pending the outcome of the meeting. The company’s executive directors are Mr. Chiu Sin Nang Kenny and Ms. Kwok Shuk Yi, while Mr. Lau Fai Lawrence, Mr. Heung Pik Lun, Mr. Diu Peter, and Mr. Yu Ping Ming serve as independent non-executive directors.